Both in Pharmaceuticals
Oruka Therapeutics vs Ionis Pharmaceuticals
Over the past year ORKA returned +269.7% and IONS returned −44.9%; their daily moves had a correlation of 0.17.
ORKA +269.7% IONS −44.9%Growth of $1, one year, split-adjusted
| Metric | ORKA | IONS |
|---|---|---|
| Price | $101.41 | $40.15 |
| Market cap | $6.71B | $6.67B |
| Today | +1.87% | −0.67% |
| 1 month | +26.5% | −8.8% |
| 6 months | +45.3% | −47.8% |
| Year to date | +234.6% | −49.2% |
| 1 year | +287.2% | −45.5% |
| Revenue growth (YoY) | — | −40.7% |
| Gross margin | — | 99.0% |
| Net margin | — | −42.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.6× |
| Net cash | $873.6M | $732.0M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 43.5% |
| Short % of float | 11.5% | 12.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).